Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0300
-0.0008 (-2.60%)
Jun 8, 2026, 2:34 PM EST

Bioxytran Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.460.510.010.030.30.07
Cash & Short-Term Investments
0.460.510.010.030.30.07
Cash Growth
10549.66%9793.56%-80.24%-91.17%308.25%73.57%
Other Current Assets
-0----
Total Current Assets
0.460.510.010.030.30.07
Long-Term Deferred Charges
0.150.150.130.110.080.05
Total Assets
0.620.660.140.140.370.12
Accounts Payable
1.10.020.0100-
Accrued Expenses
0.831.480.410.31.461.16
Short-Term Debt
1.211.251.091.932.172.12
Other Current Liabilities
1.860.50.411.010.04-
Total Current Liabilities
5.013.251.933.243.663.28
Total Liabilities
5.013.251.933.243.663.28
Common Stock
0.110.110.090.140.120.11
Additional Paid-In Capital
18.5618.31713.098.395.88
Retained Earnings
-23.11-21.04-18.92-15.7-11.22-8.75
Comprehensive Income & Other
---0.05--
Total Common Equity
-4.44-2.63-1.84-2.42-2.7-2.76
Minority Interest
----0.68-0.59-0.4
Shareholders' Equity
-4.39-2.59-1.79-3.1-3.29-3.16
Total Liabilities & Equity
0.620.660.140.140.370.12
Total Debt
1.211.251.091.932.172.12
Net Cash (Debt)
-0.75-0.74-1.09-1.9-1.87-2.05
Net Cash Per Share
-0.01-0.01-0.01-0.01-0.02-0.02
Filing Date Shares Outstanding
114.2113.3688.88166.49123.5110.84
Total Common Shares Outstanding
113.36108.1586.78145.64123.25110.84
Working Capital
-4.55-2.74-1.93-3.22-3.37-3.21
Book Value Per Share
-0.04-0.02-0.02-0.02-0.02-0.02
Tangible Book Value
-4.44-2.63-1.84-2.42-2.7-2.76
Tangible Book Value Per Share
-0.04-0.02-0.02-0.02-0.02-0.02